mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |